Sema GLP-1 (15mg)

Description

What is Semaglutide (Sema GLP-1)?

Semaglutide, also referred to as Sema or a GLP-1 receptor agonist, is a synthetic peptide studied in laboratory models for its impact on blood sugar regulation, insulin sensitivity, appetite control, and body weight modulation. It mimics the activity of glucagon-like peptide-1 (GLP-1)—a naturally occurring hormone involved in glucose metabolism and satiety signaling.

In preclinical and in vitro research, Semaglutide has been widely explored in the context of diabetes, obesity, and cardiometabolic health. Studies have examined its potential to enhance glycemic control, delay gastric emptying, and influence appetite pathways through gut-brain axis signaling. It has also been investigated for its effects on inflammatory biomarkers, fat oxidation, and long-term metabolic stability.

---

Semaglutide Product Specifications

---

Why Choose BioEdge Research Labs Semaglutide?

• High-Purity Peptide: HPLC-verified at >99% for scientific-grade consistency

• Enhanced 15mg Format: Ideal for extended metabolic and GLP-1 receptor pathway studies

• Secure Research Packaging: Light-resistant and tamper-evident vials

• Fast Shipping: Most orders ship within 24 hours after payment confirmation from our U.S.-based facility

---

Summary of Preclinical Research Findings

Diabetes and Blood Sugar Research

• Studied for how it interacts with GLP-1 receptors involved in insulin release

• Observed in laboratory models to support balanced blood sugar levels

• Examined for effects on delayed stomach emptying and post-meal glucose responses

Weight Management and Appetite Regulation

• Used in studies exploring reduced appetite and food intake in controlled models

• Linked to changes in body weight and eating behavior under lab conditions

• Evaluated for its role in supporting satiety signaling and digestion timing

Metabolic Health and Inflammation

• Studied for its impact on inflammation markers in at-risk metabolic models

• Investigated for possible influence on cardiovascular indicators and fat metabolism

• Used in long-term lab research focused on weight stability and overall metabolic balance

Note: All findings described above are based on non-human, laboratory-based research. No claims are made regarding effects in humans or animals. This product is intended strictly for scientific investigation.

---

Suggested Areas of Research

• GLP-1 receptor pathway exploration

• Blood sugar and insulin response models

• Appetite regulation and satiety signaling studies

• Weight regulation and fat mass reduction

• Gut-brain axis and gastric emptying research

• Cardiometabolic and inflammatory biomarker investigations

---

Handling & Storage Guidelines

• Store lyophilized Semaglutide at room temperature in its original container

• After reconstitution, refrigerate immediately and use within recommended time

• Use only sterile laboratory solvents

• Protect from light, heat, and humidity for maximum stability

---

For Research Use Only

Semaglutide (Sema / GLP-1) is supplied by BioEdge Research Labs exclusively for laboratory testing and in vitro research.

• Not for human or animal use

• Not for medical or diagnostic purposes

• Purchase confirms that the buyer is a qualified researcher, 18 years or older

• All usage must comply with local laws and lab safety guidelines

---

Summary of References

Semaglutide in Diabetes and Blood Sugar Regulation

• Davies, M. J., et al. (2018). Semaglutide for glycemic control in type 2 diabetes: A global phase 3a trial. Obesity Reviews, 19(5), 638–653. https://onlinelibrary.wiley.com/doi/abs/10.1111/obr.12839

• Nauck, M. A., et al. (2021). The role of GLP-1 receptor agonists in managing diabetes and obesity. Frontiers in Endocrinology, 12, Article 645563. https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.645563/full

• Lund, A., et al. (2021). Pharmacological properties of Semaglutide in patients with type 2 diabetes. Journal of Diabetes and Its Complications, 35(9), 107989. https://www.sciencedirect.com/science/article/pii/S1050173821001584

Semaglutide in Weight Loss and Appetite Regulation

• Wilding, J. P. H., et al. (2021). Once-weekly Semaglutide in adults with overweight or obesity. Diabetes, Obesity and Metabolism, 23(12), 2636–2646. https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/dom.14863

• Pi-Sunyer, X., et al. (2016). Semaglutide reduces body weight and appetite in obese individuals. New England Journal of Medicine, 375(19), 1834–1844. https://www.nejm.org/doi/abs/10.1056/nejmoa1607141

• Wilding, J. P. H., et al. (2022). Semaglutide for chronic weight management in non-diabetic individuals. Nature Medicine, 28(2), 313–320. https://www.nature.com/articles/s41591-022-02026-4

Semaglutide in Metabolic Health and Inflammation

• Blundell, J. E., et al. (2018). Appetite control and weight loss mechanisms linked to GLP-1 receptor agonists. Diabetes, Obesity and Metabolism, 20(3), 354–362. https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/dom.13361

• Davies, M. J., et al. (2024). Semaglutide and cardiovascular-metabolic risk: SURPASS-6 trial findings. New England Journal of Medicine, 390(8), 754–767. https://www.nejm.org/doi/abs/10.1056/NEJMoa2403347

 

BioEdge Research Labs
Precision. Purity. Performance.

At BioEdge, we are committed to providing research professionals with the highest quality peptides on the market. Every compound we supply is manufactured in a cGMP-certified facility, undergoes rigorous third-party testing, and is intended strictly for in vitro or laboratory research use only.